Polyphenolic Selenium Compound for Hepatitis B Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for hepatitis B are inadequate, as there is no complete cure and existing medications only partially inhibit the virus, with unsatisfactory therapeutic effects.
Innovation Solution
A polyphenolic selenium compound with an alkali metal ion and selenium coordination complex, combined with glycyrrhizin sulfate and oxymatrine, targeting hepatitis B virus, which is synthesized through hydrolyzing lignin and reacting with inorganic metal bases and SeO2, forming a complex with aromatic rings and selenium coordination groups.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional medicines are used to treat hepatitis B, then the treatment can control symptoms partially, but the therapeutic effect is far from satisfactory and cannot completely cure the disease
Solution Approach 1:
The patent employs a composite medicinal composition containing multiple active ingredients including polyphenolic selenium compound, inorganic metal base, SeO2, glycyrrhizin sulfate, and oxymatrine. This composite approach combines the antiviral, immunomodulatory, and hepatoprotective effects of different substances to achieve complete HBV clearance and liver function restoration, resolving the limitation of single-agent therapies.
Solution Approach 2:
The patent introduces a polyphenolic selenium compound with specific molecular structure parameters (selenium content >20%, specific aromatic ring structures with functional groups) to enhance viral killing efficiency. The unique chemical parameters of this compound enable complete HBV clearance rather than partial inhibition, directly addressing the insufficient therapeutic effect of conventional medicines.
2Reliability
If existing antiviral medications are administered, then HBV replication can be partially inhibited, but the virus cannot be completely eliminated and symptoms recur
Solution Approach 1:
The patent employs a multi-component formulation that continuously acts on HBV through multiple mechanisms: polyphenolic selenium compound for viral killing, glycyrrhizin sulfate for immunomodulation, and oxymatrine for hepatoprotection. This continuous multi-faceted action ensures complete and sustained viral clearance without recurrence, resolving the temporary suppression limitation of conventional drugs.
Solution Approach 2:
The patent activates the patient's own immune system through glycyrrhizin sulfate and oxymatrine components, enabling the body's immune cells to recognize and eliminate HBV autonomously. This self-service mechanism ensures long-term viral suppression without continuous high-dose medication, achieving complete clearance with sustained duration of action.
3Reliability
If polyphenolic selenium compound with high selenium content is used, then viral killing effect is enhanced, but potential toxicity may increase
Solution Approach 1:
The patent specifies precise chemical parameters for the polyphenolic selenium compound including selenium content range (>20% but controlled), specific aromatic ring structures, and functional group configurations. These optimized parameters maximize antiviral efficacy while maintaining safety by preventing selenium accumulation to toxic levels, resolving the efficacy-toxicity trade-off.
Solution Approach 2:
The patent combines polyphenolic selenium compound with other ingredients (inorganic metal base, glycyrrhizin sulfate, oxymatrine) that modulate the overall safety profile. The composite formulation distributes the functional load across multiple components, allowing high selenium content for potent antiviral activity while other components mitigate potential toxicity through synergistic protective effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound demonstrates over 20% selenium content with no toxicity, effectively killing the virus, enhancing immunity, and showing revolutionary therapeutic effects in treating hepatitis B, including inhibiting HBV, preventing liver fibrosis, and improving hepatic function.
Implementation Method 1
a selenium coordination complex functional group is formed by selenium, alkali metal ion and the mentioned functional groups
Data Source
AI summary
A compound medicine for treating acute and chronic hepatitis B, includes a polyphenolic selenium compound having a functional group of alkali metal ion and selenium coordination complex, which has functions of directly killing HBV and destroying replication template of HBV. Auxiliary formulas thereof include high-purity oxymatrine and glycyrrhizin sulfate. The oxymatrine has an effect of anti-HBV, and is capable of treating acute and chronic hepatitis B, regulating immune system and increasing leukocyte. Serving as a main hepatocyte membrane protective agent, the glycyrrhizin sulfate has not only an effect of anti-inflammation, but also it is capable of regulating immune system and protecting hepatocyte. The compound medicine has no toxicity or side effect.